News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
109last 24h
3129last 7d
511● bullish (7d)
313● bearish (7d)
227publishers
Pharmaceutical Technology132d agoneutral
Biogen trims Apellis pipeline and R&D team after $5.6bn takeoverSimply Wall St.142d agoneutral
Biogen (BIIB) Stock Could Be 10.3% Undervalued on Its Pipeline NarrativeBioPharma Dive143d agobullish
Biogen adds more immune drugs in $1B buyout of secretive startup RaytheraMT Newswires143d agoneutral
Biogen to Acquire RayThera in Up to $1 Billion Deal to Expand Immunology PipelineStocktwits144d agoneutral
BIIB Stock: Biogen Strengthens Immunology Pipeline In Up To $1B RayThera DealInsider Monkey150d agoneutral
What Makes Denali Therapeutics (DNLI) One of the Best AI Driven Biotech NamesStockStory151d agoneutral
1 Cash-Producing Stock with Impressive Fundamentals and 2 We Find RiskySimply Wall St.156d agobullish
Should Biogen’s (BIIB) New SMA Breakthrough and Lupus Data Prompt a Fresh Look From Investors?Simply Wall St.156d agobullish
A Look At Biogen (BIIB) Valuation After New Breakthrough SMA Nod And Positive Lupus Phase 3 Data